Evidence map›Paper›PMID 38031263›Full record

Trial reportClinical and experimental dental research2023

Efficacy and safety of ibuprofen gargle for postoperative pain after mandibular third molar extraction: A phase II, placebo-controlled, double-blind, randomized crossover trial.

Takeshi Ioroi, Yasumasa Kakei, Takahiro Ito, Tatsuya Shirai, Yutaro Okazaki, Takumi Hasegawa, Masaya Akashi, Ikuko Yano

Open access · goldAbstract readRandomized Controlled TrialClinical Trial, Phase II
In one paragraph

Trial report in Clinical and experimental dental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring the Role of Amitriptyline in Modulating Gag Reflex Sensitivity.Iranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Takeshi IoroiDepartment of Pharmacy, Kobe University Hospital, Hyogo, Japan.ORCID 0000-0002-9064-5106
Yasumasa KakeiDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan.ORCID 0000-0002-5997-514X
Takahiro ItoDepartment of Pharmacy, Kobe University Hospital, Hyogo, Japan.ORCID 0000-0003-2032-4443
Tatsuya ShiraiDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan.
Yutaro OkazakiDepartment of Pharmacy, Kobe University Hospital, Hyogo, Japan.ORCID 0000-0002-1014-7271
Takumi HasegawaDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan.ORCID 0000-0002-7349-7084
Masaya AkashiDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Hyogo, Japan.ORCID 0000-0003-0432-3299
Ikuko YanoDepartment of Pharmacy, Kobe University Hospital, Hyogo, Japan.ORCID 0000-0001-9517-5628
Kobe University · JPKobe University Hospital · JP

Funding

Grant-in-Aid for Young Scientists 19K16413Japan Society for the Promotion of Science KAKENHI
6 · The paper itself

Abstract

objectiveThis study was designed to evaluate the postoperative efficacy and safety of using an ibuprofen gargle as a pain management strategy for patients who have undergone mandibular third molar extraction. We also ensured that the quality of treatment was not compromised throughout the study. MATERIAL AND

methodsPatients were randomized in a 1:1 ratio into two groups: the ibuprofen-placebo (IP) group and the placebo-ibuprofen (PI) group. On postoperative Day (POD) 1, the IP group initiated ibuprofen administration, while the PI group started taking placebo. On POD 2, the IP group switched to using placebo, whereas the PI group switched to ibuprofen. From PODs 3-5, both groups were prescribed ibuprofen gargle. The primary endpoint was within-subject visual analog scale (VAS) score before and 5 min after the first use of the ibuprofen or placebo gargle on PODs 1 and 2 (ΔVAS

resultsThis study enrolled 40 patients. The within-subject VAS

conclusionIbuprofen gargle was safe but did not provide significant pain relief when used after mandibular third molar extraction.

Indexed as

IbuprofenMolar, ThirdCross-Over StudiesHumansPain ManagementPostoperative PainIbuprofenibuprofenmolarmouthwashespostoperative painthird

Identifiers

PMID38031263
PMCPMC10728546
OpenAlexW4389178804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.